Selective aortic arch perfusion: Difference between revisions
Content deleted Content added
+ref |
Added categories. |
||
| Line 6: | Line 6: | ||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
[[Category:Experimental medical treatments]] |
|||
[[Category:Bleeding]] |
|||
[[Category:Medical emergencies]] |
|||
[[Category:Interventional radiology]] |
|||
Revision as of 13:28, 22 April 2022
Selective aortic arch perfusion (SAAP) is an experimental treatment for haemorrhage-induced traumatic cardiac arrest. It has been shown in animal studies to be superior to Zone 1 REBOA once cardiac arrest has occurred.[1][2]